Received Jun 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
never got the second dose; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incomplete course of vaccination in a male patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received 1st dose on 06-NOV-2020). On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: never got the second dose). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date: 02-JUN-2025 The pharmacy intern contacted via chat and reported that the reporter had a patient get the first dose 06th November 2020 and never got the second dose. The reporter asked what do you recommend. The Vaccine Administration Facility was the same as Primary Reporter. The healthcare professional did not had the vaccine lot number nor the expiration date of the 1st Shingrix dose Also, healthcare professional did not provide consent for Safety team follow up. Till the time of reporting, the patient did not receive 2nd dose of Shingrix vaccine which led to incomplete course of vaccination.